Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 22, 2000

View Archived Issues

Blair Backs UK Biotechnology, Urges 'More Rational' Dialogue

Ethics Group Favors Research On Stem Cell Research In EU

Healthy French Baby Results From Screening Of Embryos

Galapagos, Incyte Team For Target Discovery, Validation

IDM Raises EUR48.9M To Push Trials And Add New Programs

Mirieux Gains More Control As Transgene Ousts Gilly

European Commission Plans EUR100M Outlay For Genomics

Another European Committee Plans Biotechnology Focus

Other News To Note

University Spin-off Meltec Raises DM38M In Seed Financing Round

Epigenomics To Use Money From Funding For R&D, Infrastructure

Onyvax raises #10.5M To Boost Clinical Trials For Its Vaccines

VRI Seeks A$7.5M Via IPO For Diagnostic Technologies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...